Hemispherian
Birgitte Gangmark Villmo has close to 10 years of experience in investment management and research.
In her position as Investment Manager at Investinor, she primarily focuses on the healthcare sector.
She previously worked as an Equity Analyst at Norges Bank Investment Management in Oslo/London.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Hemispherian
Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer. Its mission is to development a new drug to treat Glioblastoma Multiforme.